14358 Scientist, Prin |
| Job Description: Boston Scientific Co, the leading worldwide developer, manufacturer and marketer ... |
|
14994 Engineer, Sr S/W (SQL Developer) |
| Job Description: Participates on project teams to develop clear specifications, evaluate ... |
|
Manager, Medical Communications - MGI Pharma - Bloomington, MN |
| Manager, Medical Communications - MGI Pharma - Bloomington, MN
POSITION SUMMARY:
T... |
|
Writer, Sr Technical - 100514 - Maple Grove, MN - 0300 |
| Job Description: Responsibilities: This tech writer will work as a team member on lab deliverables ... |
|
Director, Regulatory Compliance |
| The company offers preclinical services to the biopharmaceutical and interventional device ... |
|
Director of Marketing - Cardiovascular Devices |
| We are a global endovascular technology company serving the needs of Interventional Cardiologists, R... |
|
Sr. Marketing Manager - Product Planning |
| We are a Fortune 500 cardiovascular medical device company with annual revenues in excess of $2B.&... |
|
Medical Monitor, MD |
| Advanced Clinical Services LLC has as an outstanding one-year consulting opportunity for a Board-C... |
|
PHARMACEUTICAL VALIDATION MANAGER |
| EXCELLENT MIDWESTERN PHARMACEUTICAL MANUFACTUIRNG FACILITY Validation Manager reporting to the D... |
|
Clinical Study Manager |
| St. Jude Medical, Inc. is dedicated to the design, manufacture and distribution of cardiovascular ... |
|
|
Sr. Drug Safety Specialist - MGI Pharma - Bloomington, MN
| Details |
Country: USA
Location: MN Bloomington
Total applied: 21
Relevant Work Experience: 2+ to 5 Years
Career Level: Experienced (Non-Manager)
Education Level: Bachelor's Degree
Job Type: Employee
Job Status: Full Time
|
|
Sr. Drug Safety Specialist - MGI Pharma - Bloomington, MN
Sr. Drug Safety Specialist - MGI Pharma - Bloomington, MN
Position Overview
Responsible for the appropriate and thorough reporting of adverse experiences from commercial and clinical use of MGI drugs to regulatory authorities
Critical Performance Areas
1. Timely and accurate AE processing
2. Timely and accurate SAE processing
3. Timely submission of periodic / annual reports / international responsibilities
4. Current knowledge of regulatory guidelines
Essential Job Functions
? Process adverse events according to established SOPs, FDA and ICH regulations and guidelines
? Evaluate data entry of AE / SAE?s in Oracle AERS and complete assessment of case
? Evaluate and code adverse events using the MedDRA dictionary
? Assist in validation of Oracle AERS database as required
? Provide ad hoc adverse event reports for internal use, reporting to regulatory agencies and answering partner queries
? Interact with Regulatory Affairs to ensure appropriate reporting of post marketing and clinical trial safety reports
? Interact with international partners to provide or obtain appropriate adverse event reports
? Conduct literature searches for safety reports on MGI post-marketed products
? Review materials to ensure consistency and accuracy with clinical data
? Participate on MedDRA coding team
? Provide training to Territory Managers on the reporting of adverse experiences
? Provide material and/or presentations to Sales and Marketing for periodic sales meetings
? Participate in the handling of medical communications calls
? Develop/modify SOPs and guidelines for reporting of adverse experiences
Requirements
? 4 year college degree in pharmacy, nursing
? 3+ years work experience in basic pharmaceutical research, clinical research or equivalent
? Experience in adverse event reporting
? Proficiency in PC applications
? Integrity
? Current understanding and application of FDA/ICH adverse event reporting requirements
? Excellent communication (written and verbal) skills
Other Skills/Abilities
? Advance degree in pharmacy, nursing or related science field preferred
? Oncology and Drug Safety experience desired
? MedDRA experience desired
NOTE: This job description is not intended to be all-inclusive. Associate may perform other related duties to meet the ongoing needs of the organization.
AN EQUAL OPPORTUNITY EMPLOYER
|
| Related jobs |
|
|
Business Analyst III / Sr.
PDL BioPharma, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses. T...
|
|
|
15379 Sr. Quality Engineer
Job Description: Boston Scientific's Maple Grove, MN Facility - Sr. Quality Engineer (Extrusion): Must be strongly motivated to enhance Boston Scientific's Quality M...
|
|
|
16574 Senior Chemist
Job Description: Senior Scientist within the Materials Testing, Analysis and Characterization (MTAC) R&D laboratory. Primary focus of position is Lead Analyst (subject ...
|
|
|
Research Associate - Immunoassay Dev Product Support
WHO WE ARE
R&D Systems, Inc. is a specialty manufacturer of biological products and a leader in the field of immunoassay development. We are located ...
|
|
|
16514 Engineer, Sr R&D
Job Description: Position focuses on product development including; project planning, innovative development, prototype designs, device testing, characterization, ...
|
|
|
16498 Director, R&D-MTAC
Job Description: R&D Director, Materials Testing, Analysis, and Characterization (MTAC)
Recruiting experienced lab director to provide technical and functional ...
|
|
|
Diabetes / Blood Glucose Testing Supplies National Director of Sales
GlucoCom, a Division of Cardiocom Multi-Disease Management, a leader in blood glucose testing systems, remote patient monitoring, telehealth and disease management, ...
|
|
|
Laboratory Manger
Job Description: The laboratory manager will be responsible for the following: Training & supervision of a staff of laboratory technicians/analysts and a lab coordinator....
|
|
|
14433 Quality Systems Engineer II
Job Description: Responsible for the implementation, coordination and continuous review of the CAPA system, including interface with the corporate team on potential ...
|
|
|
16156 Engineer II, R&D
Job Description: Develops new technology, products, materials, processes, or equipment with minimal supervision. Independently, or as a member of a team, develops, ...
|
|
| Related press releases |
SFI shares fall 66% as cash runs out
SFI, the high street pub group best known for the Slug and Lettuce and Bar Med, yesterday issued a profits warning and cancelled the payment of its final dividend.
Shar...
|
|
Seeing red after going Solo
Users of Solo transaction cards beware: evidence is growing of mysterious duplicate payments that can wreck careful budgeting plans by people on low incomes.
Tamsin Wil...
|
|
Vodafone frustrates Vivendi with SFR bid
Vodafone yesterday launched an audacious 13.07bn euro (£8.3bn) pre-emptive strike against struggling Franco-American media conglomerate Vivendi in the battle for Fra...
|
|
Where roads are plagued by the quick and the dead
It is one o'clock in the afternoon and I am in the back of a taxi travelling down the airport highway into town. It is 39C outside and the sun is making pretty patterns o...
|
|
Attention to details
Do you ever worry about giving your bank and credit card details over the phone? I've started to get allergic to all those disembodied call centre conversations where you...
|
|
Brawny and Clyde
Pasolini's Salo features in its credits a list of books for further reading. The press notes for Ken Loach's Sweet Sixteen contain a short essay on poverty in Scotland an...
|
|
Fight to salvage my old banger
My car was stolen in spring and I claimed on my insurance with Admiral. The car was later found damaged, and written off by Admiral largely because it was 10 years old. ...
|
|
Carlton to halve dividend, broker predicts
Carlton Communications will halve its dividend payment to shareholders to alleviate financial concerns, the ITV company's own stockbroker predicted yesterday.
Cutting t...
|
|
Beijing stumped for an answer to Washington's 'new imperialism
It is an awful prospect for President Jiang Zemin - far worse than a mass strike by laid-off workers, violent peasant protests at taxation, or any domestic upset that mig...
|
|
Inland Revenue's property sold to company in tax haven
The Inland Revenue yesterday admitted that it sold its entire property portfolio of 600 buildings to a company based in a tax haven, despite a Treasury crackdown on tax d...
|
|
|
|